Jonathan Emberson

6 ta ish

University of Oxford

1. RoB 2: a revised tool for assessing risk of bias in randomised trials

   Jonathan A C Sterne, Jelena Savović, Matthew J. Page +25

   BoshqaOAOchiq kirish201916 iqtibos

   ABIABI:AkademIndex/2026.other.125112

2. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials

   C Baigent, Colin Baigent, Lisa Blackwell +8

   Sharh maqolaOAOchiq kirish20104 iqtibos

   ABIABI:AkademIndex/2026.other.057692

3. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis

   Dena Ettehad, Connor A. Emdin, Amit Kiran +6

   Sharh maqola20154 iqtibos

   ABIABI:AkademIndex/2026.other.057698

4. Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study

   Gilbert Habib, Paola Anna Erba, Bernard Iung +85

   Maqola20194 iqtibos

   ABIABI:AkademIndex/2026.other.629872

5. Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials

   Colin Baigent, Neeraj Bhala, Jonathan Emberson +27

   Sharh maqolaOAOchiq kirish20133 iqtibos

   ABIABI:AkademIndex/2026.other.146022

6. Dexamethasone in Hospitalized Patients with Covid-19.

   RECOVERY Collaborative Group, Peter Horby, Wei Shen Lim +24

   Maqola20203 iqtibos

   ABIABI:AkademIndex/2026.other.211087